Xinyong A. Liu
State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine, Shandong Key Laboratory Of Druggability Optimization And Evaluation For Lead Compounds
Jinan, 250012, China
Jinan, 250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 371 publications
Novel Mechanisms of SARS-CoV-2 Drug Resistance and Rational Design of Anti-Resistant Antivirals.
Journal: Molecules (Basel, Switzerland)
Published: July 14, 2026
Research Progress and Challenges of Anti-monkeypox Virus Drugs Targeting F13 Protein.
Journal: Journal of medicinal chemistry
Published: July 13, 2026
Targeted Degradation of Capsid by Host-Hijacking PROTAC Overcomes Drug Resistance.
Journal: Journal of medicinal chemistry
Published: July 13, 2026
NIPBL::NACC1 fusion hepatic tumor: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: June 30, 2026
Discovery of pyridine formyl hydrazide derivatives as potent non-nucleoside RSV polymerase inhibitors.
Journal: European journal of medicinal chemistry
Published: June 23, 2026
Rational design of dual-site NNRTIs based on 2,4,5-trisubstituted pyrimidine scaffold for potent inhibition of resistant HIV-1.
Journal: European journal of medicinal chemistry
Published: June 15, 2026
Discovery of piperazine-based multi-site occupying coronavirus Mpro inhibitors with potent and broad-spectrum antiviral activity.
Journal: European journal of medicinal chemistry
Published: June 07, 2026
Pyridoimidazolyl Sulfonamide Compound 2: A Superior Dual-Acting Drug Candidate with Potent URAT1 Inhibition and Anti-Inflammatory Activity for Gout Management.
Journal: Journal of medicinal chemistry
Published: May 26, 2026
Associations between vaginal microecological status and high-risk human papillomavirus positivity in women from Eastern China: a retrospective cross-sectional study.
Journal: Frontiers in medicine
Published: May 25, 2026
Discovery of a Novel Thienopyrimidine Derivative as a Potent Dual URAT1/GLUT9 Inhibitor with Enhanced Urate-Lowering Efficacy, Superior Pharmacokinetics, and Favorable Safety Profile for Gout and Hyperuricemia.
Journal: Journal of medicinal chemistry
Published: May 06, 2026
Dual prodrugs of N4-hydroxycytidine with ProTide and ester modifications as anti-SARS-CoV-2 agents.
Journal: European journal of medicinal chemistry
Published: May 05, 2026
Last Updated: 09/26/2026